Retinoic acid affects the EGF-R signaling pathway during differentiation induction of human endometrial adenocarcinoma cells

Experimental and Molecular Pathology

Volumn 68, Issue 3, 2000, Pages 170-186

  Carter, Charleata A ^a   Shaw, Benjamin L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

EGF R; Endometrium; F actin; Gelsolin; Retinoic acid; Shc

Indexed keywords

ACTIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GELSOLIN; ISOTRETINOIN; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID;

ACTIN FILAMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENDOMETRIUM CARCINOMA; FEMALE; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; SIGNAL TRANSDUCTION;

EID: 0034041340     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.2000.2301     Document Type: Article

References (67)

1. Akiyama T., Kadowaki T., Nishida E., Kadooka T., Ogawara H., Fukama Y., Sakai H., Takaku F., Kasuga M. Substrate specificities of tyrosine-specific protein kinases toward cytoskeletal proteins in vitro. J. Biol. Chem. 261:1986;14797-14803.
2. American Cancer Society. (1998), Cancer Facts and Figures. Atlanta, GA.
3. Aronheim A., Engelberg D., Li N., Al-Alawi N., Schlessinger J., Karin M. Membrane targeting of the nucleotide exchange factor SOS is sufficient for activating the Ras signaling pathway. Cell. 78:1994;949-961.
4. Asch H. L., Head K., Dong Y., Natoli F., Winston J. S., Connolly J. L., Asch B. B. Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res. 56:1996;4841-4845.
5. Bauknecht T., Kohler M., Janz I., Pfleiderer A. The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. J. Cancer Res. Clin. Oncol. 115:1989;193-199.
6. Bretscher A. Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A431 cells by epidermal growth factor. J. Cell Biol. 108:1989;921-930.
7. Budd G. T., Adamson P. C., Gupta M., Homayoun P., Sandstrom S. K., Murphy R. F., McLain D., Tuason L., Peereboom D., Ganapathi R. D. Phase I/II trial of all trans-retinoic acid and tamoxifen in patients with advanced breast cancer. Clin. Cancer Res. 4:1998;635-642.
8. Carter C. A., Rinehart C. A., Bagnell C. R., Kaufman D. G. Fluorescent laser scanning microscopy of F-actin disruption in human endometrial stromal cells expressing the SV40 large T antigen and the EJ ras oncogene. Pathobiology. 59:1991;36-45.
9. Carter C. A., Pogribny M., Davidson A., Jackson C. D., McGarrity L. J., Morris S. M. Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (RL95-2) cells. Anticancer Res. 16:1996;17-24.
10. Carter C. A., Parham G. P. State of differentiation affects the response of endometrial adenocarcinoma cells to retinoic acid. Anticancer Res. 17:1997;1973-1984.
11. Carter C. A., Parham G. P., Chambers T. C. Cytoskeletal reorganization induced by retinoic acid treatment of human endometrial adenocarcinoma (RL95-2) cells is correlated with alterations in protein kinase C-α Pathobiology. 66:1998;284-292.
12. Carter C. A., Bellido T. Decrease in protein tyrosine phosphorylation is associated with F-actin reorganization by retinoic acid in human endometrial adenocarcinoma (RL95-2) cells. J. Cellular Physiol. 178:1999;320-332.
13. Chen P., Murphy-Ullrich J. E., Wells A. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J. Cell Biol. 134:1996;689-698.
14. Cochet C., Gill G. N., Meisenhelder J., Cooper J. A., Hunter T. C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem. 259:1984;2553-2558.
15. DeLuca L. M. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J. 5:1991;2924-2933.
16. Dieffenbach C. W., SenGupta D., Krause D., Sawzak D., Silverman R. H. Cloning of murine gelsolin and its regulation during differentiation of embryonal carcinoma cells. J. Biol. Chem. 264:1989;13281-13288.
17. Dosaka-Akita H., Hommura F., Fujita H., Kinoshita I., Nishi M., Morikawa T., Katoh H., Kawakami Y., Kuzumaki N. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res. 58:1998;322-327.
18. Downward J. The ras superfamily of small GTP-binding proteins. Trends Biochem. Sci. 15:1990;469-472.
19. Fava R. A., Cohen S. Isolation of a calcium-dependent 35-kilodalton substrate for the epidermal growth factor receptor kinase from A431 cells. J. Biol. Chem. 265:1984;16725-16728.
20. Guo W. X., Gill P. S., Antakly T. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation. Cancer Res. 55:1995;823-829.
21. Helige C., Smolle J., Zellnig G., Hartmann E., Fink-Puches R., Kerl H., Tritthart H. A. Inhibition of K1735-M2 melanoma cell invasion in vitro by retinoic acid. Clin. Exp. Metast. 11:1993;409-418.
22. Hong W. K., Itri L. M. Retinoids and human cancer. Sporn M. B., Roberts A. B., Goodman D. S. The Retinoids: Biology, Chemistry, and Medicine. 1994;Raven Press, New York.
23. Hunter T., Ling N., Cooper J. A. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplaslic face of the plasma membrane. Nature (Lond.). 311:1984;480-483.
24. Janmey P. A., Chaponnier C., Lind S. E., Zaner K. S., Stossel T. P., Yin H. L. Interactions of gelsolin and gelsolin actin complexes with actin. Effects of calcium on actin nucleation, filament severing and end blocking. Biochemistry. 24:1985;3714-3723.
25. Kolega J. Effects of mechanical tension on protrusive activity and microfilament and intermediate filament organization in an epidermal epithelium moving in culture. J. Cell Biol. 102:1986;1400-1411.
26. Kore M., Haussler C. A., Trookman N. S. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Cancer Res. 47:1987;4909-4914.
27. Kudelka A. P., Freedman R. S., Edwards C. L., Lippman S. M., Tornos C. S., Krakoff I. H., Kavanagh J. J. Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-α Anti-Cancer Drugs. 4:1993;335-337.
28. Kwiatkowski D. J., Mehl R., Yin H. L. Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J. Cell Biol. 106:1988;375-384.
29. Kwiatkowski D. J. Functions of gelsolin: Motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 11:1999;103-108.
30. Kwon H. J., Yoshida M., Nagaoka R., Obinata T., Beppu T., Horinouchi S. Suppression of morphological transformation by radicicol is accompanied by enhanced gelsolin expression. Oncogene. 15:1997;2625-2631.
31. Lee H. K., Driscoll D., Asch H., Asch B., Zhang P. J. Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate. Prostate. 40:1999;14-19.
32. Lehtonen E., Lehto V-P., Badley R. A., Virtanen I. Formation of vinculin plaques precedes other cytoskeletal changes during retinoic acid-induced teratocarcinoma cell differentiation. Exp. Cell Res. 144:1983;191-197.
33. Lelle R. J., Talavera F., Gretz H., Roberts J. A., Menon K. M. Epidermal growth factor receptor expression in three different human endometrial cancer cell lines. Cancer. 72:1993;519-525.
34. Levi F., Franceschi S., Negri E., La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer. 71:1993;3575-3581.
35. Lin T. H., Mukku V. R., Verner G., Kirkland J. L., Stancel G. M. Autoradiographic localization of epidermal growth factor receptors to all major uterine cell types. Biol. Reprod. 38:1988;403-411.
36. Lotti L. V., Lanfrancone L., Migliaccio E., Zompetta C., Pelicci G., Salcini A. E., Falini B., Pelicci P. G., Torrisi M. R. Shc proteins are localized on endoplasmic reticulum membranes and are redistributed after tyrosine kinase receptor activation. Mol. Cell Biol. 16:1996;1946-1954.
37. Malliri A., Symons M., Hennigen R. F., Hurlstone A. F., Lamb R. F., Wheeler T., Ozanne B. W. The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J. Cell Biol. 143:1998;1087-1099.
38. 1 cells. Am. J. Kidney Dis. 22:1993;858-864.
39. Meyer W. H., Howard T. H. Changes in actin content during induced myeloid maturation of human promyelocytes. Blood. 62:1983;308-314.
40. Negri E., Vacchia C. L., Franceschi S., Levi F., Parazzini F. Intake of selected micronutrients and the risk of endometrial carcinoma. Cancer. 77:1996;917-923.
41. Niikura H., Sasano H., Kaga K., Sato S., Yajima A. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. Hum. Pathol. 27:1996;282-290.
42. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grihnani F., Pawson T., Pelicci P. G. A novel transforming protein (SHC) with an SH2 domain implicated in mitogenic signal transduction. Cell. 70:1992;93-104.
43. Peppelenbosch M. P., Tertoolen L. G. J., Hage W. J., de Laat S. W. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell. 74:1993;565-575.
44. Pienta K. J., Partin A. W., Coffey D. S. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res. 49:1989;2525-2532.
45. Rao J. Y., Hurst R. E., Bales W. D., Jones P. L., Bass R. A., Archer L. T., Bell P. B., Hemstreet G. P. Cellular F-actin levels as a marker for cellular transformation: Relationship to cell division and differentiation. Cancer Res. 50:1990;215-2220.
46. Reynolds R. K., Talavera F., Roberts J. A., Hopkins M. P., Menon K. M. J. Characterization of epidermal growth factor receptor in normal and neoplastic endometrium. Cancer. 66:1990;1967-1974.
47. Ridley A. J., Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 70:1992;389-399.
48. Rijken P. J., Hage W. J., Van Bergen En Henegouwen P. M. P., Verkleij A. J., Boonstra J. Epidermal growth factor induces rapid reorganization of the actin microfilament system in human A431 cells. J. Cell Sci. 100:1991;491-499.
49. Rijken P. J., Post S. M., Hage W. J., Van Bergen En Henegouwen P. M. P., Verkleij A. J., Boonstra J. Actin polymerization localizes to the activated epidermal growth factor receptor in the plasma membrane, independent of the cytosolic free calcium transient. Exp. Cell Res. 218:1995;223-232.
50. Rijken P. J., van Hal G. J., van der Heyden M. A. G., Verkleij A. J., Boonstra J. Actin polymerization is required for negative feedback regulation of epidermal growth factor-induced signal transduction. Exp. Cell Res. 243:1998;254-262.
51. Ross S. A., Ahrens R. A., DeLuca L. M. Retinoic acid enhances adhesiveness, laminin and integrin β1 synthesis and retinoic acid receptor expression in F9 teratocarcinoma cells. J. Cell Physiol. 159:1994;263-273.
52. Roulier S., Rochette-Egly C., Rebut-Bonneton C., Porquet D., Evain-Brion D. Nuclear retinoic acid receptor characterization in cultured human trophoblast cells: Effect of retinoic acid on epidermal growth factor receptor expression. Mol. Cell Endocrinol. 105:1994;165-173.
53. Rozakis-Adcock M., McGlade J., Mbamalu G., Pelicci G., Daly R., Li W., Batzer A., Thomas S., Brugge J., Pelicci P. G., Schlessinger J., Pawson T. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 360:1992;689-692.
54. Savage C. R., Cohen S. Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J. Biol. Chem. 247:1972;7609-7611.
55. Schlessinger J., Ullrich A. Growth factor signalling by receptor tyrosine kinases. Neuron. 9:1992;383-391.
56. Schlessinger J. SH2/SH3 signaling proteins. Curr. Opin. Genet. Dev. 4:1994;25-30.
57. Stossel T. P., Chaponnier C., Ezell R. M., Hartwig J. H., Janmey P. A., Kwiatkowski D. J., Lind S. E., Smith D. B., Southwick F. S., Yin H. L., Zaner K. S. Nonmuscle actin-binding proteins. Annu. Rev. Cell Biol. 1:1985;353-402.
58. Tanaka M., Müllauer L., Ogiso Y., Fujita H., Moriya S., Furuuchi K., Harabayash T., Shinohara N., Koyanagi T., Kuzumaki N. Gelsolin: A candidate for suppressor of human bladder cancer. Cancer Res. 55:1995;3228-3232.
59. Thomas D., Patterson S. D., Bradshaw R. A. Src homologous and collagen (Shc) protein binds to F-actin and translocates to the cytoskeleton upon nerve growth factor stimulation in PC12 cells. J. Biol Chem. 270:1995;28924-28931.
60. Thompson K. L., Rosner M. R. Regulation of epidermal growth factor receptor gene expression by retinoic acid and epidermal growth factor. J. Biol. Chem. 263:1989;3230-3234.
61. Tornus C., Elvio S. Pathology and grading of endometrial adenocarcinomas. Clin. Consult. Obstet. Gynecol. 5:1993;87-95.
62. Underwood B. A. Vitamin A in animal and human nutrition. Sporn M. B., Roberts A. B., Goodman D. S. The Retinoids. 1:1984;Academic Press, London.
63. Welsch J. B., Gill G. N., Rosenfeld M. G., Wells A. A negative feedback loop attenuates EGF-induced morphological changes. J. Cell Biol. 114:1991;533-543.
64. Wiegant F. A. C., Blok F. J., Defize L. H. K., Linnemens W. A. M., Verkley A. J., Boonstra J. Epidermal growth factor receptors associated to cytoskeletal elements of epidermoid carcinoma (A431) cells. J. Cell Biol. 103:1986;87-94.
65. 2+-dependent regulatory protein of actin gel-sol transformation: Its intracellular distribution in a variety of cells and tissues. J. Cell Biol. 9:1981;901-906.
66. Yin H. L. Gelsolin: Calcium- and polyphosphosphoinositide-regulated modulating protein. Bioessays. 7:1988;176-179.
67. Zarcone R., Bellini P., Cardone G., Vicinanza G., Cardone A. Epidermal growth factor receptor expression: Is it the same in normal and malignant endometria? Clin. Exp. Obstet. Gynecol. 22:1995;298-300.